Renovaro receives Nasdaq deficiency notice for bid price below $1; 180-day cure period

Lunai Bioworks Inc.

Nasdaq notified Renovaro on Sept 12, 2024 that stock failed minimum $1 bid price for 30 consecutive business days.
Company has 180 calendar days (until March 11, 2025) to regain compliance by closing at or above $1 for 10 consecutive days.
If not cured, Renovaro may qualify for an additional 180-day period by meeting other listing standards.
Stock continues trading under symbol RENB; company is evaluating options to regain bid price compliance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.